Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

83 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Completed

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

NCT03744676

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Local Institution - 0057 Los Angeles, California, United States
  • Local Institution - 0060 Denver, Colorado, United States
  • Local Institution - 0089 Miami, Florida, United States
  • Local Institution - 0081 Orlando, Florida, United States
View all 23 locations
View Trial Details
Completed

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

NCT03150862

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Center For Neurosciences Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • University of California At San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
View all 22 locations
View Trial Details
Completed

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

NCT02112656

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Toronto General Hospital Toronto, Ontario, Canada
  • Mengchao Hepatobiliary Hospital of Fujian Medicatl University Fuzhou, Fujian, China
  • Xijing Hospital Xi'an, Shaanxi, China
View all 61 locations
View Trial Details
Completed

Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma

NCT01183949

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Centre New York, United States
View Trial Details
Completed

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

NCT02658968

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +29 more
Locations
  • University of California, San Diego (UCSD) - Moores Cancer Center San Diego, California, United States
  • University of California, San Francisco (UCSF) - Innovation, Technology & Alliances San Francisco, California, United States
  • Sylvester Comprehensive Cancer Centre Miami, Florida, United States
  • Klinikum rechts der Isar der TU München Munich, Germany
View Trial Details
Completed

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

NCT02993731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute (CCI) Huntsville, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 267 locations
View Trial Details
Completed

A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer

NCT02753127

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +11 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 211 locations
View Trial Details

Related conditions